Aspirin for Prevention and Treatment of Cardiovascular Disease

被引：11
|
作者：
Mehta, Shamir R. [1 ]
机构：
[1] McMaster Univ, Hamilton Gen Hosp, Hamilton, ON L8L 2X2, Canada
来源：
ANNALS OF INTERNAL MEDICINE | 2009年 / 150卷 / 06期
关键词：
ACUTE CORONARY SYNDROMES; CLOPIDOGREL; EVENTS; TRIAL;
D O I：
10.7326/0003-4819-150-6-200903170-00011
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：414 / 416
页数：3
相关论文
共 50 条
  • [1] Aspirin for secondary prevention of cardiovascular disease
    Byrne, Robert A.
    Colleran, Roisin
    LANCET, 2020, 395 (10235) : 1462 - 1463
  • [2] Revisiting the Role of Aspirin for the Primary Prevention of Cardiovascular Disease
    Marquis-Gravel, Guillaume
    Roe, Matthew T.
    Harrington, Robert A.
    Munoz, Daniel
    Hernandez, Adrian F.
    Jones, W. Schuyler
    CIRCULATION, 2019, 140 (13) : 1115 - 1124
  • [3] Rivaroxaban with or without aspirin for prevention of cardiovascular disease
    Kruger, Paul C.
    Eikelboom, John W.
    Yusuf, Salim
    CORONARY ARTERY DISEASE, 2018, 29 (05) : 361 - 365
  • [4] Aspirin in the Treatment and Prevention of Cardiovascular Disease: Past and Current Perspectives and Future Directions
    Hennekens, Charles H.
    Dalen, James E.
    AMERICAN JOURNAL OF MEDICINE, 2013, 126 (05) : 373 - 378
  • [5] Aspirin in the primary prevention of cardiovascular disease
    Galloway, Colin F.
    Stevenson, John C.
    MATURITAS, 2011, 68 (01) : 3 - 4
  • [6] The role of aspirin in cardiovascular disease prevention
    Wagenaar, Peter
    CARDIOVASCULAR JOURNAL OF AFRICA, 2012, 23 (05) : 300 - 300
  • [7] Aspirin in the treatment and prevention of cardiovascular disease: Current perspectives and future directions
    Hennekens C.H.
    Current Atherosclerosis Reports, 2007, 9 (5) : 409 - 416
  • [8] Aspirin for Primary Prevention of Atherosclerotic Cardiovascular Disease Advances in Diagnosis and Treatment
    Mora, Samia
    Manson, JoAnn E.
    JAMA INTERNAL MEDICINE, 2016, 176 (08) : 1195 - 1204
  • [9] Contemporary Reflections on the Safety of Long-Term Aspirin Treatment for the Secondary Prevention of Cardiovascular Disease
    Fanaroff, Alexander C.
    Roe, Matthew T.
    DRUG SAFETY, 2016, 39 (08) : 715 - 727
  • [10] Aspirin for Primary and Secondary Prevention of Cardiovascular Disease: Time to Stop?
    Cleland, John G. F.
    THROMBOSIS AND HAEMOSTASIS, 2022, 122 (03) : 311 - 314
12345